Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP intrauterine infusion after hysteroscopic adhesiolysis for moderate to severe intrauterine adhesions
ChiCTR2500104042Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of platelet-rich plasma, Normal Saline-Benha University and DehydraTECH-estrogen in Intrauterine Adhesions (IUA) (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: ESGE score for intrauterine adhesions. Started Jun 2025; status: recruiting.
02
Drugs
platelet-rich plasmaNormal Saline-Benha UniversityDehydraTECH-estrogen
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on ChiCTR2500104042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104042.